Adler, Sabine <br/><br/>
Risk of relapse after discontinuation of tocilizumab therapy in giant cell arteritis.  [electronic resource] 

 -  Rheumatology (Oxford, England)  09 2019 
 - 1639-1643 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1462-0332 
<br/><br/><label>Standard No.: </label>10.1093/rheumatology/kez091  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Biomarkers--blood<br/>Drug Administration Schedule<br/>Female<br/>Follow-Up Studies<br/>Giant Cell Arteritis--diagnostic imaging<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Kaplan-Meier Estimate<br/>Magnetic Resonance Angiography<br/>Male<br/>Middle Aged<br/>Recurrence<br/>Remission Induction<br/>Risk Assessment--methods<br/>Risk Factors<br/>Withholding Treatment